2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow seladelpar: new trials by email Literature Review of seladelpar trials Research Report on seladelpar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-Label Study Following Oral Dosing of Seladelpar to Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI) Seladelpar - Primary Biliary Cholangitis, Compensated Cirrhosis | Phase 1 | Completed | Gilead Sciences | 24 | 2021-11-16 | 2026-05-04 |
| Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Seladelpar in Subjects With Hepatic Impairment and Healthy Subjects seladelpar - Hepatic Impairment | Phase 1 | Completed | Gilead Sciences | 32 | 2017-11-27 | 2018-05-18 |
Gilead Sciences (2)
United States (2) · South Korea (1) · Spain (1) · United Kingdom (1)